Marijuana’s Potential Makes This Biotech Stock One of My Favorites | Traderszone

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 13 June, 2015 by The TZ Newswire Staff

Marijuana’s Potential Makes This Biotech Stock One of My Favorites

Insys Therapeutics has filed for FDA approval of oral dronabinol, a formulation of the marijuana cannabinoid THC.

See also
- Next Article GoPro Inc. Has Big Plans for The Cloud
- Previous Article 3 Double-Digit Dividend Yields in Danger of Being Cut
Editorial Calender

June 2015

M T W T F S S

1 2 3 4 5 6 7

8 9 10 11 12 13 14

15 16 17 18 19 20 21

22 23 24 25 26 27 28

29 30

« May Jul »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar